The translational regenerative medicine market has been undergoing considerable changes over the last few years. There are a number of therapies that have been launched into the market over the last few years. Stem cell therapies are being developed constantly and these are targeted at various indications, from the more common cardiovascular conditions to rarer orphan indications.
The Global Translational Regenerative Medicine market is expected to grow significantly over the forecast period. The Global Translational Regenerative Medicine market was valued at $5.8bn in 2016. Visiongain forecasts this market to increase to $14.5bn in 2021. The market is estimated to grow at a CAGR of 19.9% in the first half of the forecast period and 17.7% from 2016 to 2027.
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new Visiongain report you find 316-page report you will receive 107 tables and 66 figures– all unavailable elsewhere.
The 316-page report provides clear detailed insight into the Global Translational Regenerative Medicine market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand new report today you stay better informed and ready to act.
Download your free report sample pages here: https://www.visiongain.com/Report/1843/Global-Translational-Regenerative-Medicine-Market-Prospects-2017-2027
Translational Regenerative Medicine regional market forecasts from 2017-2027, covering:
– United States
– Rest of the World
• Global Translational Regenerative Medicine submarket forecasts from 2017-2027 covering:
– Stem Cell Therapies
– Tissue Engineered Products
– Gene Therapies
• Forecasts from 2017-2027 of the leading products in the Global Translational Regenerative Medicine market:
– Osteocel Plus
– Trinity ELITE
– TEMCELL /Prochymal
– Glybera (alipogene tiparvovec)
– IMLYGIC (talimogene laherparepvec)
See the report full table of contents here:
• Assessment of the leading companies in the Global Translational Regenerative Medicine market:
– Alphatec Spine
– Avita Medical
– Ocata Therapeutics
– Osiris Therapeutics
– Vericel Corporation
• SWOT and Porter’s Five Force analysis of the translational regenerative medicine market
Visiongain’s study is intended for anyone requiring commercial analyses for the Translational Regenerative Medicine Market and leading companies. You find data, trends and predictions.
Buy our report today Global Translational Regenerative Medicine Market Prospects 2017-2027: Stem Cell Therapies, Tissue Engineered Products, Gene Therapies.
Request your free report overview today. Please email Sara Peerun on firstname.lastname@example.org or call me on +44 (0) 207549 9987.
Advanced Tissue Sciences
BioMed Realty Trust, Inc
BrainStorm Cell Therapeutics
California Stem Cell Inc
Cook Biotech Inc
DePuy Mitek (Johnson & Johnson)
Gamida Cell Ltd
Genzyme Corporation (Sanofi)
Human Stem Cell Institute
Janssen Biotech Inc
Japan Tissue Engineering Co
Johnson & Johnson
Kinetic Concept Inc
Lincoln Park Capital
Nippon Zoki Pharmaceuticals
Orphan Biovitrum AB (Sobi)
Reliance Life Sciences
Shanghai Sunway Biotech
Shenzhen Sibiono GeneTech
Singapore General Hospital
Smith & Nephewbv
TCA Cellular Therapy
U.S. Stem Cell Inc.
WKD Holding Oy
Company Name: Visiongain Limited
Contact Person: Sara Peerun
Email: Send Email
Phone: +44 207 3366100
Address:143 Airport House, Purley way
City: London CR0 0XZ
Country: United Kingdom